Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 54 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
531 17.2 months Advanced metastatic colorectal cancer 4 Chemotherapy
Hospital Universitario Reina Sofia Spain 4/2004
Treatment Details: Patients: This Phase II trial involved 36 patients with advanced metastatic colorectal cancer. Treatment: The treatment consisted of two chemotherapy drugs – irinotecan (camptosar) and 5
 
532 17.2 months Metastatic, castration-resistant prostate cancer 4 Chemotherapy
Hormone
University Hospital of Cologne Germany 10/2012
Treatment Details: Patients: This phase 2 study involved metastatic castration-resistant prostate cancer who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Gr
 
533 17.1 months Malignant glioma 4 Immunotherapy
China Medical University and Hospital Taiwan Region 8/2011
Treatment Details: Patients: This study involved 17 malignant glioma patients with an average age of 44.7 years; 8 were male. Treatment: Patients were treated with an autologous dendritic cell tumor vacci
 
534 17.1 months Platinum-resistant primary epithelial ovarian carcinoma 4 Biologic therapy
Chemotherapy
The West Clinic United States 2/2013
Treatment Details: Patients: This phase 2 study involved 48 primary epithelial ovarian or peritoneal carcinoma patients who had previously received platinum-based chemotherapy. The average patient age was 61
 
535 17.1 months Refractory/recurrent ovarian cancer 5 Chemotherapy
Vall d’Hebron University Hospital Spain 3/2013
Treatment Details: Patients: This phase 2 study involved 295 refractory/recurrent ovarian cancer patients with a median age of 58 years. Treatment: Patients were treated with the chemotherapy agent called
 
536 17.1 months Ovarian cancer 4 Chemotherapy
Instituto Valenciano de Oncologı´a Spain 1/2011
Treatment Details: Patients: This study involved ovarian cancer patients with partially platinum-sensitive relapse after previous platinum-based therapy. Patients were divided into two separate treatment gro
 
537 17.1 months Metastatic colorectal cancer 5 Chemotherapy
National Tumour Institute Italy 2/2009
Treatment Details: Patients: This study involved 322 patients with metastatic colorectal cancer. Of these, a little over half (58%) were men. They ranged in age from 37-84, and the median age was 63 years o
 
538 17.1 months Recurrent ovarian cancer 5 Chemotherapy
Massachusetts General Hospital United States 12/2007
Treatment Details: Patients: This phase II study involved 147 women with recurrent ovarian cancer. All had received a platinum therapy before entering the study. The median age was 59 years, ranging from 33
 
539 17.1 months Locally advanced or metastatic breast cancer 4 Chemotherapy
Kidwai Memorial Institute of Surgical Oncology India 11/2007
Treatment Details: Patients: This phase III study involved 368 women with estrogen- or progesterone-receptor positive locally advanced or metastatic breast cancer. Treatment: Patients were treated with
 
540 17.0 months metastatic breast cancer 4 Chemotherapy
University of North Carolina United States 8/2006
Treatment Details: Patients: This phase II study involved 55 women. The median age was 58, ranging from 27-82 years old. 67% of women estrogen receptor positive tumors and 49% had progesterone receptor posi
 
Page 54 of 187  | Previous Page  | Next Page